Sunday - June 2, 2024

Antibody Variable Domains Targeting the NKG2D Receptor

2024-03-26

ALEXANDRIA, Virginia, March 26 -- DRAGONFLY THERAPEUTICS, INC., Waltham, Massachusetts has been assigned a patent (No. US 11939384 B1, initially filed Nov. 3, 2023) developed by six inventors Gregory P. Chang, Medford, Massachusetts; Ann F. Cheung, Lincoln, Massachusetts; Asya Grinberg, Lexington, Massachusetts; William Haney, Wayland, Massachusetts; Bradley M. Lunde, Lebanon, New Hampshire; and Bianka Prinz, Lebanon, New Hampshire, for "Antibody variable domains targeting the NKG2D receptor." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Antibody Variable Domains Targeting the NKG2D Receptor

Information Request Form

Copyright Targeted News Service 2024